Related Experiment Video
Updated: May 17, 2026

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
[AMP-activated protein kinase-alpha is involved in the autophagy and apoptosis caused by troglitazone]
Xin Jin1, Dongdong Yuan, Xiuling Chen
1State Key Laboratory of Mycology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China. michelle.jinxin@163.com
Objective:
To reveal the mechanism of AMPK signaling in the autophagy and apoptosis caused by troglitazone (TZ).
Methods:
To investigate the effect of TZ on alteration of autophagy and apoptosis in HeLa cells, fluorescence microscopy, electron microscopy, western-blotting, siRNA interference, flow cytometry and MTS assay were used.
Results:
TZ attenuated AMP-activated protein kinase-alpha (AMPKalpha) phosphorylation, and stimulates autophagic process in HeLa cells. TZ induced the accumulation of microtubule-associated protein 1 light chain 3-II (LC3-II), and degradation of sequestosome 1 (SQSTM1/p62), two markers of autophagy, occurring prior to the caspase activation. Compound C, an AMPK inhibitor, increased basal and inhibits TZ-stimulated LC3-II content and TZ-depended PARP cleavage. Knockdown of the gene encoding autophagic proteins and AMPK conferred the cells resistance to apoptosis by TZ.
Conclusion:
Taken together, these data demonstrate that AMPK is involved in TZ promote autophagy, which precedes and contributes to caspase-dependent apoptosis.
Insights
Troglitazone (TZ) activates autophagy via AMP-activated protein kinase (AMPK) signaling, preceding apoptosis. Inhibiting AMPK blocks TZ-induced autophagy and cell death, revealing AMPK
Area of Science:
- Cellular Biology
- Molecular Biology
- Biochemistry
Background:
- Troglitazone (TZ) is known to induce cell death.
- The precise mechanisms underlying TZ-induced apoptosis and autophagy remain incompletely understood.
- AMP-activated protein kinase (AMPK) signaling pathways are implicated in cellular stress responses.
Purpose of the Study:
- To elucidate the role of AMPK signaling in troglitazone-induced autophagy and apoptosis.
- To investigate the temporal relationship between autophagy and apoptosis.
- To determine if AMPK activation is a prerequisite for TZ-induced cell death.
Main Methods:
- HeLa cells were treated with troglitazone (TZ).
- Autophagy was assessed using markers like LC3-II and SQSTM1/p62 via western blotting.
- Apoptosis was evaluated through caspase activation and PARP cleavage.
- AMPK activity was modulated using siRNA interference and the inhibitor Compound C.
- Cell viability was measured using MTS assay.
Main Results:
- TZ treatment reduced AMPK phosphorylation and stimulated autophagy in HeLa cells.
- TZ induced accumulation of LC3-II and degradation of SQSTM1/p62, preceding caspase activation.
- AMPK inhibition by Compound C blocked TZ-stimulated autophagy and PARP cleavage.
- Knockdown of autophagy-related genes or AMPK conferred resistance to TZ-induced apoptosis.
Conclusions:
- AMPK signaling is crucial for mediating troglitazone-induced autophagy.
- TZ-induced autophagy precedes and contributes to caspase-dependent apoptosis.
- Targeting the AMPK-autophagy pathway may offer therapeutic strategies for TZ-related effects.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Cellular Injury V: Apoptosis and Autophagy
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Apoptosis
cAMP-dependent Protein Kinase Pathways
